HIV-1 replication in the central nervous system occurs in two distinct cell types

PLoS Pathogens

Volumn 7, Issue 10, 2011, Pages

  Schnell, Gretja ^a   Joseph, Sarah ^a   Spudich, Serena ^b   Price, Richard W ^b   Swanstrom, Ronald ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5;

ARTICLE; CD4+ T LYMPHOCYTE; CELL TYPE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTROLLED STUDY; GENE AMPLIFICATION; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLEOCYTOSIS; T LYMPHOCYTE ACTIVATION; UNINDEXED SEQUENCE; VIRAL TROPISM; VIRUS REPLICATION; BIOSYNTHESIS; BLOOD; CELL LINE; CELL STRAIN HEK293; CYTOLOGY; LEUKOCYTOSIS; MOLECULAR GENETICS; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AIDS DEMENTIA COMPLEX; ANTIGENS, CD4; CELL LINE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; GENETIC VARIATION; HEK293 CELLS; HIV-1; HUMANS; LEUKOCYTOSIS; MACROPHAGES; MOLECULAR SEQUENCE DATA; RECEPTORS, CCR5; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 80055096215     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002286     Document Type: Article

References (66)

1. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, et al. (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239: 586-592.
2. Boisse L, Gill MJ, Power C, (2008) HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol Clin 26: 799-819.
3. Bell JE, (2004) An update on the neuropathology of HIV in the HAART era. Histopathology 45: 549-559.
4. Gisolf EH, Enting RH, Jurriaans S, de Wolf F, van der Ende ME, et al. (2000) Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine. AIDS 14: 1583-1589.
5. Gonzalez-Scarano F, Martin-Garcia J, (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5: 69-81.
6. Pomerantz RJ, (2003) Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1. HIV Clin Trials 4: 137-143.
7. Schrager LK, D'Souza MP, (1998) Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. JAMA 280: 67-71.
8. Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, et al. (2008) Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 63: 213-221.
9. Jevtovic D, Vanovac V, Veselinovic M, Salemovic D, Ranin J, et al. (2009) The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART. Biomed Pharmacother 63: 561-565.
10. Ances BM, Ellis RJ, (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 27: 86-92.
11. Fischer-Smith T, Rappaport J, (2005) Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Rev Mol Med 7: 1-26.
12. Gorry PR, Bristol G, Zack JA, Ritola K, Swanstrom R, et al. (2001) Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol 75: 10073-10089.
13. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, et al. (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089-1093.
14. Rossi F, Querido B, Nimmagadda M, Cocklin S, Navas-Martin S, et al. (2008) The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors. Retrovirology 5: 89.
15. Thomas ER, Dunfee RL, Stanton J, Bogdan D, Taylor J, et al. (2007) Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Virology 360: 105-119.
16. Gorry PR, Taylor J, Holm GH, Mehle A, Morgan T, et al. (2002) Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J Virol 76: 6277-6292.
17. Peters PJ, Bhattacharya J, Hibbitts S, Dittmar MT, Simmons G, et al. (2004) Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J Virol 78: 6915-6926.
18. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, et al. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123-126.
19. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, et al. (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122.
20. Schnell G, Spudich S, Harrington P, Price RW, Swanstrom R, (2009) Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia. PLoS Pathog 5: e1000395.
21. Haas DW, Clough LA, Johnson BW, Harris VL, Spearman P, et al. (2000) Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma. AIDS Res Hum Retroviruses 16: 1491-1502.
22. Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, et al. (2000) Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 54: 927-936.
23. Alexander M, Lynch R, Mulenga J, Allen S, Derdeyn CA, et al. (2010) Donor and recipient envs from heterosexual human immunodeficiency virus subtype C transmission pairs require high receptor levels for entry. J Virol 84: 4100-4104.
24. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, et al. (2009) Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 206: 1273-1289.
25. Ritola K, Robertson K, Fiscus SA, Hall C, Swanstrom R, (2005) Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J Virol 79: 10830-10834.
26. Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K, et al. (2009) Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS 23: 907-915.
27. Dunfee RL, Thomas ER, Gorry PR, Wang J, Taylor J, et al. (2006) The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Proc Natl Acad Sci U S A 103: 15160-15165.
28. Ohagen A, Devitt A, Kunstman KJ, Gorry PR, Rose PP, et al. (2003) Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J Virol 77: 12336-12345.
29. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, et al. (1994) Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 68: 4643-4649.
30. Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, et al. (2008) Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol 82: 3952-3970.
31. Johnston SH, Lobritz MA, Nguyen S, Lassen K, Delair S, et al. (2009) A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains. J Virol 83: 11016-11026.
32. Harrington PR, Haas DW, Ritola K, Swanstrom R, (2005) Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells. J Virol 79: 7959-7966.
33. Brew BJ, Bhalla RB, Paul M, Gallardo H, McArthur JC, et al. (1990) Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol 28: 556-560.
34. Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, et al. (2010) Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther 7: 15.
35. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, et al. (1996) Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10: 573-585.
36. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, et al. (1996) Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 39: 705-711.
37. von Herrath M, Oldstone MB, Fox HS, (1995) Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. J Immunol 154: 5582-5589.
38. Phares TW, Kean RB, Mikheeva T, Hooper DC, (2006) Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol 176: 7666-7675.
39. Zhao J, Perlman S, (2009) De novo recruitment of antigen-experienced and naive T cells contributes to the long-term maintenance of antiviral T cell populations in the persistently infected central nervous system. J Immunol 183: 5163-5170.
40. Budka H, (1986) Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol 69: 253-258.
41. Navia BA, Cho ES, Petito CK, Price RW, (1986) The AIDS dementia complex: II. Neuropathology. Ann Neurol 19: 525-535.
42. Everall IP, Hansen LA, Masliah E, (2005) The shifting patterns of HIV encephalitis neuropathology. Neurotox Res 8: 51-61.
43. Kraft-Terry SD, Stothert AR, Buch S, Gendelman HE, (2010) HIV-1 neuroimmunity in the era of antiretroviral therapy. Neurobiol Dis 37: 542-548.
44. Dunfee RL, Thomas ER, Wang J, Kunstman K, Wolinsky SM, et al. (2007) Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia. Virology 367: 222-234.
45. Musich T, Peters PJ, Duenas-Decamp MJ, Gonzalez-Perez MP, Robinson J, et al. (2011) A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection. J Virol 85: 2397-2405.
46. Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant RM, et al. (1999) Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS 13: 1051-1061.
47. Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, et al. (1999) Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS 13: 1677-1685.
48. Schnell G, Price RW, Swanstrom R, Spudich S, (2010) Compartmentalization and Clonal Amplification of HIV-1 Variants in the Cerebrospinal Fluid during Primary Infection. J Virol 84: 2395-2407.
49. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, et al. (2003) Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 31: 3497-3500.
50. Thompson JD, Higgins DG, Gibson TJ, (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
51. Katoh K, Toh H, (2008) Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform 9: 286-298.
52. Guindon S, Lethiec F, Duroux P, Gascuel O, (2005) PHYML Online-a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res 33: W557-559.
53. Guindon S, Gascuel O, (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52: 696-704.
54. Slatkin M, Maddison WP, (1989) A cladistic measure of gene flow inferred from the phylogenies of alleles. Genetics 123: 603-613.
55. Pond SL, Frost SD, Muse SV, (2005) HyPhy: hypothesis testing using phylogenies. Bioinformatics 21: 676-679.
56. Kumar S, Nei M, Dudley J, Tamura K, (2008) MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 9: 299-306.
57. Kumar S, Tamura K, Nei M, (1994) MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers. Comput Appl Biosci 10: 189-191.
58. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
59. Connor RI, Chen BK, Choe S, Landau NR, (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206: 935-944.
60. He J, Choe S, Walker R, Di Marzio P, Morgan DO, et al. (1995) Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 69: 6705-6711.
61. Baba M, Nishimura O, Kanzaki N, Okamoto M, Sawada H, et al. (1999) A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A 96: 5698-5703.
62. Dragic T, Trkola A, Thompson DA, Cormier EG, Kajumo FA, et al. (2000) A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc Natl Acad Sci U S A 97: 5639-5644.
63. Bridger GJ, Skerlj RT, Thornton D, Padmanabhan S, Martellucci SA, et al. (1995) Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker. J Med Chem 38: 366-378.
64. De Clercq E, Yamamoto N, Pauwels R, Balzarini J, Witvrouw M, et al. (1994) Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother 38: 668-674.
65. Hendrix CW, Flexner C, MacFarland RT, Giandomenico C, Fuchs EJ, et al. (2000) Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother 44: 1667-1673.
66. O'Doherty U, Swiggard WJ, Malim MH, (2000) Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74: 10074-10080.